Overview
Cypherpunk Technologies reports Q3 net loss of $3.3 mln, down from $18.2 mln last year
Company acquires 203,775 ZEC for $50 mln as part of digital asset strategy
Closed $58.88 mln private placement led by Winklevoss Capital for digital asset strategy
Outlook
Company did not provide specific financial guidance for future quarters or year
Result Drivers
DIGITAL ASSET STRATEGY - Co established a digital asset treasury strategy focused on Zcash, acquiring over 203,775 ZEC for $50 mln
CLINICAL TRIAL RESULTS - Co presented final data from Phase 2 trial of sirexatamab in CRC patients, showing significant benefits
PRIVATE PLACEMENT - Co closed $58.88 mln private placement led by Winklevoss Capital to fund digital asset strategy
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Net Income | -$3.30 mln |
Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the biotechnology & medical research peer group is "buy."
Press Release: ID:nPrezDBSka
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)